Disclosures for "Impact of Direct Transportation to a Thrombectomy Center vs Closest Primary Stroke Center on Treatment Times Among Non-Urban Patients Undergoing Mechanical Thrombectomy in a Large Healthcare System"
-
Abdullah Al Qudah has nothing to disclose.
-
The institution of Dr. Martin-Gill has received research support from Pittsburgh Emergency Medicine Foundation. The institution of Dr. Martin-Gill has received research support from Department of Defense / US Army. The institution of Dr. Martin-Gill has received research support from National Institute of Health. The institution of Dr. Martin-Gill has received research support from Defense Advanced Research Projects Agency (DARPA). The institution of Dr. Martin-Gill has received research support from American Academy of Sleep Medicine (AASM) . The institution of Dr. Martin-Gill has received research support from Pediatric Pandemic Network (PPN) . The institution of Dr. Martin-Gill has received research support from American College of Medical Toxicology (ACMT).
-
Dr. Dermigny has nothing to disclose.
-
Mr. Doheim has nothing to disclose.
-
Dr. Rios Rocha has nothing to disclose.
-
Dr. Sultany has nothing to disclose.
-
The institution of Dr. Rocha has received research support from NIH.
-
Dr. Starr has nothing to disclose.
-
Dr. Correia Lima has nothing to disclose.
-
Dr. Al-Bayati has nothing to disclose.
-
The institution of Dr. Guyette has received research support from DoD.
-
Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.
-
Dr. Bhatt has nothing to disclose.